Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 12
Item hits:
Issue DateTitleAuthor(s)
19-Jan-2016Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotype.Zheng, F; Yue, C; Li, G; He, B; Cheng, W, et al
27-Jun-2016p62/SQSTM1 enhances breast cancer stem-like properties by stabilizing MYC mRNAXu, LZ; Li, SS; Zhou, W; Kang, ZJ; Zhang, QX, et al
13-Jul-2016Aurora-A Kinase: A Potent Oncogene and Target for Cancer TherapyYan, M; Wang, C; He, B; Yang, M; Tong, M, et al
31-Jan-2016Insights into a Critical Role of the FOXO3a-FOXM1 Axis in DNA Damage Response and Genotoxic Drug ResistanceNestal de Moraes, G; Bella, L; Zona, S; Burton, MJ; Lam, EW, et al
25-Feb-2016In vitro methods for studying the mechanisms of resistance to DNA-damaging therapeutic drugsKhongkow, P; Middleton, AK; Wong, JP; Kandola, NK; Kongsema, M, et al
1-Jan-2016Sirtuin1 (SIRT1) in the Acetylation of Downstream Target Proteins.Gomes, AR; Yong, JS; Kiew, KC; Aydin, E; Khongkow, M, et al
12-Aug-201611a-N-Tosyl-5-deoxi-pterocarpan, LQB-223, a novel compound with potent antineoplastic activity toward breast cancer cells with different phenotypes.Lemos, LG; Nestal de Moraes, G; Delbue, D; Vasconcelos, FD; Bernardo, PS, et al
29-Sep-2016FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer.Marzi, L; Combes, E; Vié, N; Ayrolles-Torro, A; Tosi, D, et al
6-Apr-2016Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteinsGuaita-Esteruelas, S; Bosquet, A; Saavedra, P; Gumà, J; Girona, J, et al
31-Aug-2016Role and regulation of the forkhead transcription factors FOXO3a and FOXM1 in carcinogenesis and drug resistanceGomes, AR; Zhao, F; Lam, EW